Stromal gene expression predictive of metastatic primary prostate cancer
Clinical grading systems that use clinical characteristics, as well as nomograms, do not have the accuracy to guide treatment decisions for prostate cancer (prostate cancer). There is a critical need to identify biomarkers that can more accurately stratify men with primary prostate cancer
Institutions
- Tashkent Medical Academy (UZ)
Publication Details
- Journal
- Zenodo (CERN European Organization for Nuclear Research)
- Published
- 2025-06-28
- DOI
- https://doi.org/10.5281/zenodo.15762435
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00